Clinical Trial

A Study of Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe Aplastic Anemia

Name: A Study of Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe Aplastic Anemia — clinical trial record (NCT07345000)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This is a randomized, double-blind, multicenter trial designed to evaluate treatment with romiplostim N01+ IST compared with placebo + IST in the participants with treatment-naïve severe aplastic anemia.

Trial Details

NCT Number	NCT07345000
Lead Sponsor	Qilu Pharmaceutical Co., Ltd.
Conditions	Treatment-naïve Severe Aplastic Anemia
Enrollment	210 participants
Start Date	2026-01
Primary Completion	2029-10 (estimated)
Study Completion	2030-08 (estimated)
Updated on ClinicalTrials.gov	2026-01-15